Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

ABVC BioPharma, Inc.

 

We hereby consent to the inclusion by reference in this Registration Statement on Form S-8 of ABVC BioPharma, Inc. (the “Company”), to be filed on or about November 16, 2026, of our report dated March 3, 2026, with respect to our audit of the Company’s consolidated financial statements as of December 31, 2025, and 2024 and for the years then ended.

 

 

Rowland Heights, California

November 16, 2026